SHANDONG, China, March 16, 2020, On March 15, 2020, Mr. Fengfeng Lu, CEO of SPO Global Inc, visited the headquarters of Lanchuang Technology Ltd., CEO Li Libo introduced the his companys operation , rapid online hospital, standardized pharmacy chain's easy-to-diagnosis management platform,, and the future development strategy of the Chinese medical market. Lanchuang Technology is willing to participate in the cooperation in the development of Gerpang Healthcare Group Fuyutang Traditional Chinese Medicine Franchises to jointly create an innovative business model of a standardized online platform for medicine.
About Lanchuang Technology Ltd. Lanchuang Technology Co., Ltd. is a leading high-tech company with artificial intelligence as its core, product development, production and Internet healthcare operation in China and holds dozens of Chinese and international patents.
About SPO Global Inc SPO Global Inc. (OTC Markets: SPOM) recently completed its merger with Gerpang Healthcare Group. (www.gerpanghealthcare.com). Its subsidiary, Shandong Gerpang Biotechnology Co., Ltd. is an innovative and technological private enterprise located in the pharmaceutical Valley Industrial Park of Jinan high tech Zone. Its main business scope includes biomedical R&D, medical information software development and sales, medical high-tech introduction, medical high-quality consumables production and sales, health care products, drugs, medical equipment consumables agency and sales.
Company Disclaimers: As a "penny stock" Company, within the meaning of federal and state securities law, SPO Global, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, SPO Global, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment. Forward-Looking Statements: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission.
Company Contact: fengyoulu@gmail.com
Source: SPO Global Inc.